The Real-World Lifetime Economic Burden of Urothelial Carcinoma by Stage at Diagnosis.

Aly, Abdalla; Johnson, Courtney; Doleh, Yunes; Chirikov, Viktor; Botteman, Marc; Shenolikar, Rahul; Hussain, Arif

Aly, Abdalla; Johnson, Courtney; Doleh, Yunes; Chirikov, Viktor; Botteman, Marc; Shenolikar, Rahul; Hussain, Arif.

Afiliação

Aly A; AstraZeneca, Gaithersburg, MD.
Johnson C; Pharmerit International, Bethesda, MD.
Doleh Y; AstraZeneca, Gaithersburg, MD.
Chirikov V; Pharmerit International, Bethesda, MD.
Botteman M; Pharmerit International, Bethesda, MD.
Shenolikar R; AstraZeneca, Gaithersburg, MD.
Hussain A; University of Maryland School of Medicine, Baltimore, MD.

J Clin Pathw ; 6(4): 51-60, 2020 May.

Article em En | MEDLINE | ID: mdl-32832698

Palavras-chave

Immunotherapy; SEER-Medicare; administrative claims; bladder cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Health_economic_evaluation Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google